Background
==========

The environmental occurrence of pharmaceuticals, steroid hormones, pesticides and personal-care products, collectively termed as trace organic contaminants (TOrCs) or contaminants of emerging concern (CECs), has been consistently reported for over a decade \[[@B1]-[@B4]\]. The recalcitrance of certain TOrCs and their ability to pass through conventional drinking water treatment trains has necessitated frequent monitoring of these chemicals \[[@B5]-[@B7]\]. While the effects of many TOrCs on public health remains largely unknown, studies have shown that some of these contaminants can have drastic effects on aquatic organisms at concentrations present in wastewater \[[@B8],[@B9]\]. In addition, other studies have demonstrated that a combination of TOrCs can have synergistic effects on some organisms \[[@B9],[@B10]\].

Numerous studies have focused on the analysis of estrogens, both natural and synthetic \[[@B11]-[@B13]\], but relatively less literature is available on the occurrence and analysis of other endocrine disruptors (glucocorticoids, progestins and androgens) in aquatic environments. Glucocorticoid receptor-active compounds (GRs) are known to control inflammation and infections and hence both natural and synthetic GRs have been used to prevent swelling, asthma and other diseases in humans \[[@B14]\]. This increased use combined with the fact that most GRs are poorly adsorbed in the human body and quickly excreted has led to their recent detection in wastewater and surface waters worldwide \[[@B14]-[@B16]\]. In this work we expanded the list of steroids typically included for analysis to include an androgen (testosterone), progestins (norethisterone and norgestrel) along with several GRs.

Polyfluorinated compounds (PFCs) are a relatively new sub-class of compounds within the TOrC classification. These compounds are synthetically produced and have a wide-range of applications, including in non-stick cookware, stain-resistant carpets, and surfactants among other things \[[@B17]\]. This frequent usage along with their inherent biological and chemical stability make PFCs persistent in the environment and frequently detected in water \[[@B17],[@B18]\], biosolids \[[@B19]\] and biological matrices \[[@B20]\]. Consequently, the two most commonly used PFCs (PFOA and PFOS) are on the USEPA's Contaminant Candidate List 3 \[[@B21]\]. In addition, bioaccumulation properties, potential carcinogenicity and recent reports on toxic effects to animals \[[@B22],[@B23]\] have led to the voluntary reduction in usage of PFOA and the banning of PFOS in Europe \[[@B24]\]. However, these two compounds are progressively being replaced by shorter chain (C \< 7) PFC's \[[@B25]\], of which far less is known with regards to toxicity and occurrence data. Accordingly, this study set out to include six PFCs with C4-C16 carbon chain length.

Over 82,000 chemicals are registered for industrial use in the US and the number is rapidly increasing \[[@B26]\]. Monitoring each chemical is not feasible; hence the significance of selecting 'indicator' compounds that encompass the various classes of TOrCs is critical. Recent studies have sought to identify indicator TOrCs based on their occurrence and attenuation in the environment \[[@B27]\]. This study selected 36 disparate compounds across seven classes of TOrCs for analysis using a single extraction method and short analysis time.

As the number of environmental contaminants monitored continues to increase rapidly, the need for reliable analytical methods offering selectivity, sensitivity and reproducibility also has increased. Over the years, numerous methods relying on a variety of instruments were developed to measure TOrCs. For instance, gas chromatography has been used to analyze volatile compounds and pesticides as well as some polar compounds and steroids using derivatization agents \[[@B28],[@B29]\]. However, these techniques are time-consuming, labor intensive and limited to the analysis of compounds that are volatile and not thermally-labile.

Liquid chromatography methods have proved more effective in analyzing TOrCs. While methods using UV \[[@B30],[@B31]\] and fluorescence \[[@B32],[@B33]\] detectors have been proposed, methods using both single quadrupole \[[@B34],[@B35]\] and triple quadrupole \[[@B36],[@B37]\] mass spectrometers have been most common. However, the vast majority of these methods consider only specific classes of pharmaceuticals \[[@B38],[@B39]\] or compounds with similar polarities and/or use numerous extraction methods that are time-consuming and labor-intensive. Only few methods use a single extraction procedure while still analyzing a wide variety of these compounds \[[@B29],[@B40],[@B41]\]. With the introduction of ultra-high performance liquid chromatography (UHPLC), it is now possible to operate at extremely high pressures with much smaller particle sizes which allows for rapid separation of analytes while also improving resolution and sensitivity.

This study aims to provide a simple, rapid, sensitive and robust method for the targeted analysis of 36 compounds (Table  [1](#T1){ref-type="table"}) representative of several TOrC classes usually considered by water utilities and regulatory agencies. The method includes several different classes of TOrCs including less studied substances like GRs and PFCs. The application of UHPLC allows for a significant reduction in sample runtime while providing good analytical separation compared to previously published methods and also providing very low ng/L detection limits in water. The proposed method includes the addition of 19 stable isotopically labeled compounds to increase accuracy and precision. This method was successfully applied to groundwater, surface water and wastewater matrices.

###### 

Target compounds with use and class

                **Compound**                        **Use**                   **Class**
  ---------------------------------------- -------------------------- --------------------------
                  Atrazine                         Pesticide                  Pesticide
                Benzophenone                       UV Blocker           Personal Care Product
                Bisphenol A                       Plasticizer            Industrial compound
                  Caffeine                         Stimulant            Personal Care Product
               Carbamazepine                     Anticonvulsant             Pharmaceutical
     N,N-Diethyl-meta-toluamide (DEET)          Insect Repellant        Personal Care Product
               Dexamethasone                   Anti-Inflammatory            Glucocorticoid
                 Diclofenac                      Anti-arthritic             Pharmaceutical
                 Diltiazem                       Antiarrhythmic             Pharmaceutical
              Diphenhydramine                    Anti-histamine             Pharmaceutical
                 Fluoxetine                     Anti-Depressant             Pharmaceutical
                Gemfibrozil                     Anti-Cholesterol            Pharmaceutical
         Hydrocortisone (Cortisol)             Anti-inflammatory            Glucocorticoid
                 Ibuprofen                         Analgesic                Pharmaceutical
                Meprobamate                       Anti-anxiety              Pharmaceutical
                  Naproxen                         Analgesic                Pharmaceutical
               Norethisterone                    Contraceptive                Progestin
                 Norgestrel                      Contraceptive                Progestin
       Perfluoro butanoic acid (PFBA)           Fluorosurfactant       Polyfluorinated Compound
     Perfluoro butane sulfonate (PFBS)          Fluorosurfactant       Polyfluorinated Compound
       Perfluoro decanoic acid (PFDA)           Fluorosurfactant       Polyfluorinated Compound
    Perfluoro hexadecanoic acid (PFHxDA)        Fluorosurfactant       Polyfluorinated Compound
       Perfluoro octanoic acid (PFOA)           Fluorosurfactant       Polyfluorinated Compound
     Perfluoro octane sulfonate (PFOS)          Fluorosurfactant       Polyfluorinated Compound
                 Prednisone                    Anti-inflammatory            Glucocorticoid
                 Primidone                       Anticonvulsant             Pharmaceutical
                  Simazine                         Herbicide                  Pesticide
                 Sucralose                    Artificial Sweetener      Personal Care Product
              Sulfamethoxazole                     Antibiotic               Pharmaceutical
   Tris (2-chloroethyl) phosphate (TCEP)        Flame retardant          Industrial compound
   Tris (2-chloropropyl) phosphate (TCPP)       Flame retardant          Industrial compound
                Testosterone                        Androgen                   Androgen
               Triamcinolone                Synthetic corticosteroid        Glucocorticoid
                Triclocarban                       Antibiotic           Personal Care Product
                 Triclosan                       Anti-microbial         Personal Care Product
                Trimethoprim                       Antibiotic               Pharmaceutical

Experimental
------------

### Chemicals and reagents

All standards and reagents used during the study were of the highest purity commercially available (≥97% for all compounds). All native standards were procured from Sigma-Aldrich (St. Louis, MO) except perfluorohexadecanoic acid (PFHxDA) from Matrix Scientific (Columbia, SC); meprobamate from Cerilliant (Round Rock, TX); and triclosan from Alfa Aesar (Ward Hill, MA). Labeled standards were purchased from Cambridge Isotope Laboratories (Andover, MA) except ^13^C~4~-PFOA, ^13^C~4~-PFOS, ^13^C~2~-PFHxA, ^13^C~4~-PFBA from Wellington Laboratories (Ontario, Canada); primidone-d~5~ and ^13^C~6~-diclofenac from Toronto Research Chemicals (Ontario, Canada); and gemfibrozil-d~6~ from C/D/N Isotopes (Quebec, Canada). A working stock of all native standards was prepared at 5 mg/L in pure methanol and diluted as required to obtain the desired concentration of calibration standards. A mix of all isotopically labeled surrogates at 1 mg/L in pure methanol was also prepared and used to spike all samples before extraction. These two solutions were stored in the dark at −20°C and new working stocks were prepared every two months. Both stocks were injected routinely on the mass spectrometer and signal response was monitored for each compound to determine if there was any degradation with time.

All solvents were of the highest purity available and suitable for LC-MS analysis. Methanol (HPLC grade), MTBE (HPLC grade), formic acid (LC/MS grade) and ammonium hydroxide (ACS grade) were obtained from Fisher Scientific (Pittsburgh, PA), while acetonitrile and ultrapure water (both HPLC grade) were obtained from Burdick and Jackson (Muskegon, MI).

### Sample collection and preservation

Grab samples were collected from four full-scale water treatment plants across the United States. In addition, multiple samples from two surface waters and a groundwater from Tucson, Arizona were analyzed. Samples (1 L each) were collected in silanized amber glass bottles containing 50 mg of ascorbic acid to quench residual chlorine and 1 g of sodium azide to prevent microbial activity. Samples were sent to the laboratory in coolers containing icepacks and filtered through a 0.7 μm glass filter (Whatman, England) immediately upon arrival. Then, samples were stored in darkness at 4°C and extracted within 14 days. Sample preservation techniques were comparable to those previously published by Vanderford *et al.*\[[@B42]\].

### Solid-phase extraction

All samples were spiked with 19 isotopically labeled surrogate standards at concentrations varying from 50 to 200 ng/L depending on analytical sensitivity and matrix type. Samples were then extracted using an AutoTrace 280 automated SPE system from Dionex (Sunnyvale, CA) using 200 mg hydrophilic-lipophilic balance (HLB) cartridges (Waters Corporation; Millford, MA). Cartridges were first preconditioned with 5 ml of MTBE, followed by 5 ml of methanol and 5 ml of ultrapure water. Samples were then loaded at 15 ml/min onto the cartridges which were subsequently rinsed with ultrapure water and dried under nitrogen flow for 30 min. While 1 L samples were collected, different volumes of sample were extracted based on the matrix. The analytes were then eluted with 5 ml of methanol followed by 5 ml of 10/90 (v/v) methanol/MTBE solution. The eluent was evaporated to less than 500 μl using gentle nitrogen flow and the volume was adjusted to 1 ml by addition of methanol. Final extracts were transferred into 2-mL vials and stored in darkness at 4°C until UHPLC-MS/MS analysis.

### Liquid chromatography

Liquid chromatography was performed on 3 μL of sample extract using an Agilent 1290 binary pump (Palo Alto, CA) with metal solvent fittings for all analyses. The Agilent RRHD ZORBAX Eclipse Plus reverse phase C-18 column (2.1×50 mm) with a packing size of 1.8 μm was used to separate analytes in both the negative and positive electrospray ionization (ESI) modes. The column was maintained at a temperature of 30°C for the entire run in both modes.

The mobile phase for ESI positive used two solvents comprising (A) ultrapure water with 0.1% formic acid and (B) acetonitrile with 0.1% formic acid. With a constant flowrate of 400 μl/min, solvent B was held at 5% for 1.5 min. Solvent B then linearly increased to 20% at 3 min, 45% at 4 min, 65% at 6.1, 100% at 7 min and held till 7.45 min. A post-run of 1.45 min was added to allow the column to re-equilibrate before the next analysis. This resulted in a total run-time of 9.90 min for analysis of 23 analytes (Additional file [1](#S1){ref-type="supplementary-material"}: Table S1 and Figure  [1](#F1){ref-type="fig"}).

![**Extracted ion chromatogram (quantifiers only) of 100 μg/L standard mixture in ESI positive.a)** caffeine, **b)** trimethoprim, **c)** sucralose, **d)** primidone **e)** sulfamethoxazole, **f)** meprobamate, **g)** triamcinolone, **h)** hydrocortisone, **i)** prednisone, **j)** simazine, **k)** carbamazepine, **l)** fluoxetine **m)** dexamethasone **n)** TCEP, **o)** atrazine, **p)** testosterone, **q)** norethisterone, **r)** TCPP, **s)** norgestrel, **t)** benzophenone, **u)** diphenhydramine, **v)** diltiazem **w)** DEET. Qualifier ion and surrogate standard chromatograms have been removed for clarity.](1752-153X-7-104-1){#F1}

The mobile phase for ESI negative used a dual eluent system comprising (A) 5 mM ammonium acetate in ultrapure water and (B) 10/90 (v/v) water/acetonitrile with 5 mM ammonium acetate. With a constant flowrate of 400 μl/min, solvent B was linearly increased from 20% to 96% at 4.5 min and 100% at 5 min. Solvent B was held at 100% for a further 1.3 min then a post-run of 1.5 min at 20% B was added to allow the column to re-equilibrate before the next analysis. This resulted in a total run-time of 7.8 min for the analysis of 13 analytes (Additional file [1](#S1){ref-type="supplementary-material"}: Table S1 and Figure  [2](#F2){ref-type="fig"}). Sample chromatograms for positive and negative ionization modes at 100 ng/mL are shown in Figures  [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}.

![**Extracted ion chromatogram (quantifier only) of 100 μg/L standard mixture in ESI negative.a)** PFBA, **b)**naproxen, **c)** PFBS, **d)** diclofenac, **e)** Ibuprofen, **f)** PFOA, **g)** bisphenolA, **h)** gemfibrozil, **i)** PFDA, **j)** PFOS, **k)** triclocarban, **l)** triclosan, **m)** PFHxDA. Qualifier ion and surrogate standard chromatograms have been removed for clarity.](1752-153X-7-104-2){#F2}

### Mass spectrometry

Mass spectrometry was performed using an Agilent 6460 triple quadrupole mass spectrometer. Optimization was done in two steps: compound-specific and source-dependent. Initially, each compound was prepared from a neat standard at a concentration of 1 μg/ml in pure methanol and injected into the mass spectrometer at a flowrate of 500 μl/min. The first quadrupole was set to scan mode and the most intense precursor ion was selected. This was done both in positive and negative electrospray modes to select the most appropriate ion source for each compound. After the best ion source was chosen, the fragmentor voltage was optimized for each compound in scan mode. After this, the mass spectrometer was run in product ion scan (PI Scan) mode to determine the most abundant product. For this, collision energy (CE) of 20 volts was selected and then adjusted in steps of 10 to find the most abundant products. For most compounds, two transitions; a quantifier (the most abundant product) and a qualifier (the second most abundant product) were selected. Then, the mass spectrometer was set to multiple reaction monitoring (MRM) mode and the CE for each product ion was optimized. This was followed by optimization of the cell accelerator voltage (CAV); however, it was noticed that there was a possibility of cross talk between some compounds especially at low CAVs so this value was only optimized between two and seven. The analyte transitions, optimized parameters and retention times are given in Additional file [1](#S1){ref-type="supplementary-material"}: Table S1.

Once all the compound-specific parameters were optimized, source parameters like gas temperature, flow rate, nozzle voltage, nebulizer and capillary voltage were tuned. While, it was not possible to have optimum source parameters to suit all the compounds, best fit values were used in choosing these parameters. The source-dependent parameters for both positive and negative electrospray ionization modes are detailed in Table  [2](#T2){ref-type="table"}. Analysis in both ESI modes was performed using a dynamic MRM method with a delta retention time of 0.6 min for ESI positive mode and 0.8 min for ESI negative mode.

###### 

Mass spectrometer source-dependent parameters

          **Parameter**          **ESI Positive**   **ESI Negative**
  ----------------------------- ------------------ ------------------
      Gas Temperature (°C)             275                225
      Gas Flowrate (L/min)              11                 10
         Nebulizer (psi)                45                 45
   Sheath Gas Temperature (°C)         375                350
   Sheath Gas Flowrate (L/min)          11                 11
          Capillary (V)                4000               3600
       Nozzle Voltage (V)               0                 1500
          Delta EMV (V)                400                400

Data analysis and interpretation was carried out with the Agilent MassHunter software (version Rev. B.05.00). Along with monitoring the labeled isotope recoveries and the retention time, the ratio of the two transitions was also noted, which increased the accuracy of detection and reduced the possibility of false positives of the method.

### Determination of LOD, LOQ and MRL

The instrumental limit of detection (LOD) and limit of quantification (LOQ) were determined for each compound by injecting standards at 0.02, 0.05, 0.1, 0.5, 1, 2.5, 5, 10 and 25 μg/L on the UHPLC-MS/MS system. The LOD and LOQ were defined as the concentration for which the signal to noise ratio (SNR) was greater than 3 and 10 respectively. The LOD and LOQ of all target analytes are shown in Table  [3](#T3){ref-type="table"}.

###### 

LOD, LOQ and MRL of target analytes

     **Compound**      **LOD (μg/L)**   **LOQ (μg/L)**   **Practical MRL (ng/L)**
  ------------------- ---------------- ---------------- --------------------------
   **ESI positive**                                     
       Caffeine             0.5               1                    2.5
     Trimethoprim           0.05             0.1                   0.1
       Sucralose             1                5                     10
     Triamcinolone           1               2.5                    5
       Primidone             1               2.5                   2.5
   Sulfamethoxazole         0.02              .1                    .5
      Meprobamate           0.1               1                    2.5
   Diphenylhydramine        0.02             0.1                    1
       Diltiazem            0.02             0.1                   0.5
    Hydracortisone          0.5               1                    2.5
      Prednisone             10               15                    20
       Simazine             0.1              0.5                    1
      Fluoxetine            0.02             0.05                  0.5
     Carbamazepine          0.05             0.1                   0.25
     Dexamethasone          0.05             0.5                    1
         TCEP               0.5               1                    2.5
       Atrazine             0.1              0.5                   0.5
         DEET               0.05             0.1                  2.5\*
     Testosterone           0.5               1                     1
     Norethistrone          0.1              0.5                    1
         TCPP               0.05              1                    2.5
      Norgestrel            0.5               1                    2.5
     Benzophenone           0.02             0.5                    1
   **ESI negative**                                     
         PFOA               0.02             0.5                    1
         PFDA               0.02             0.5                   2.5
      Gemfibrozil           0.05             0.5                    1
         PFOS               0.02             0.05                  0.1
     Triclocarban           0.1              0.5                    1
       Triclosan            0.5              2.5                    5
        PFHxDA              0.02             0.1                   0.5
         PFBS               0.02             0.05                  0.5
         PFBA               0.02             0.02                   NA
       Ibuprofen             5                10                    15
      Bisphenol A            1                5                     15
       Naproxen             0.1               1                    2.5
      Diclofenac            0.1              0.5                   2.5

*NA* Not analyzed; \* Adjusted for blank.

The method reporting limit (MRL) was determined by extracting nine samples (1 L each) of ultrapure water fortified with the target analytes at 2--3 times the LOQ (calculated from above) and spiked with isotopically-labeled surrogates. After extraction and analysis, the MRL was calculated by multiplying the standard deviation with the student's t-test value for n-1 degrees of freedom at 99% confidence levels. The results are shown in Table  [3](#T3){ref-type="table"}. The method reporting limits determined were similar and in many cases lower than previously published literature \[[@B29],[@B43]\].

Results and discussion
======================

Chromatography
--------------

Optimization of chromatographic conditions was achieved by performing experiments with various mixtures of organic solvents and pH modifying buffers. The best mobile phase was chosen based on peak shape, peak resolution and sensitivity achieved for all compounds. Three different UHPLC reverse phase columns were also tested and the column providing the highest sensitivity for most target analytes was chosen. Details of the three columns tested are provided in Additional file [2](#S2){ref-type="supplementary-material"}: Table S2. Once the column and the mobile phase were selected, the gradients in both modes were optimized to achieve best separation of all target analytes while maintaining a sufficient scan speed and peak width to preserve peak shape allowing accurate integration. In addition, different injection volumes (1, 3, 5 and 10 μl) were also tested and 3 μl was used for all analysis as this gave the highest sensitivity without alteration of peak shape.

Analyte ionization and data analysis
------------------------------------

All but one compound were ionized by protonation\[(M + H)^+^\] of the uncharged molecule in the ESI positive mode. Sucralose was analyzed with the addition of a sodium adduct \[(M + Na)^+^\] as the \[(M + H)^+^\] ion was essentially absent during optimization of the compound. In the ESI negative mode, all the compounds analyzed were a result of deprotonation \[(M-H)^-^\] of the original neutral molecule.

The quantification of TOrCs in all samples was achieved using a calibration curve with at least nine points and an R^2^ no lower than 0.990 and typically above 0.995. All concentrations above the calibration range were diluted and re-analyzed. In a few instances, it was not possible to determine the exact concentration of an analyte due to loss of isotope signal because of dilution. In this case, concentration were reported as '\>' the highest calibration point. While the MRL for all TOrCs was reported in ultrapure water, this value could be impaired in other water matrices containing natural organic matter that interfere with the ionization of the analytes. To account for this, a separate MRL was determined for each sample. Initially, the lowest calibration point was chosen at or slightly above the MRL determined in ultrapure water. Using the Mass Hunter software, the expected concentrations of the calibration curve were recalculated based on the calibration equation and R^2^ using a linear regression with 1/X weighting. After comparing the calculated concentrations of all the calibration points with expected concentrations, the lowest calibration point with accuracy between 70-130% was chosen for each analyte. This value was then divided by the isotope recovery obtained for all analytes in each sample to obtain the "true" MRL in that particular sample matrix.

Matrix spike and recoveries
---------------------------

Recoveries for the target analytes after extraction were determined using six replicates in three different water matrices shown in Table  [4](#T4){ref-type="table"}. Matrix spike levels were chosen as 100 ng/L in ultrapure water and 200 ng/L in surface water and wastewater samples. The spike recoveries were calculated by comparing this known spiking concentration with the concentration determined in unspiked samples by internal standard calibration. For ultrapure water, more than 70% of the compounds had a recovery between 90--110%. Only two compounds (diltiazem and PFHxDA) had a recovery of \<70%. The recoveries in the surface water varied from 39--121% while wastewater recoveries ranged from 38--141%. While these ranges seem large, it is important to note that isotopically-labeled surrogate standards were not available for every compound. All compounds with a surrogate standard had corrected recoveries between 73--121% with the exception of diclofenac (64%) in the wastewater spike. In fact, almost all these compounds had recoveries of 85 -- 115% further validating the use of isotope dilution to correct for matrix suppression and losses during SPE. The recovery of norgestrel and norethisterone were below 60% in the surface water and wastewater spike samples. Previous studies have shown that these two compounds have poor stability on storage greater than three days and this may have led to loss of analyte in the sample \[[@B44]\]. While every effort was made to extract the samples as soon as possible, extraction times varied between 3--14 days during this study. Spike recoveries for hydrocortisone were found to be 50% and 38% in surface water and wastewater respectively. Similar recoveries (\~60%) have been seen in a previous study in wastewater \[[@B16]\]. To obtain better recoveries for all compounds, the use of multiple extraction procedures, and considering compound specific properties would be necessary. It was decided to proceed with this single extraction method that provided good recoveries for the majority of the compounds while allowing for significant savings in time and labor. The precision of the entire method was good as the relative standard deviation (RSD) of the replicates for almost all compounds was less than 10% in both ultrapure and surface water. While larger RSDs were observed for wastewater samples, compounds with surrogate standards were still extremely reproducible. Overall, the use of surrogate standards to correct for loss of target analytes during the extraction and analysis stages proved reliable.

###### 

Matrix spike recoveries for all target analytes in three different waters

     **Compounds**     **Ultrapure water**   **Surface water**   **WW effluent**               
  ------------------- --------------------- ------------------- ----------------- ------ ----- ------
   **ESI positive**                                                                            
       Caffeine                106                  2.5                95          4.3    100   3.9
     Trimethoprim              98                   2.1                102         0.9    114   3.2
       Sucralose               95                   5.4                73          34.1   NA     NA
       Primidone               97                   2.9                96          1.5    113   10.0
     Triamcinolone             101                  4.7                48          2.3    106   4.3
   Sulfamethoxazole            105                  3.3                98          1.7    99    2.1
      Meprobamate              97                    5                 74          1.5    99    8.4
   Diphenylhydramine           74                   5.4                94          5.4    196   3.8
       Diltiazem               67                  11.7                NA           NA    NA     NA
    Hydracortisone             84                   3.7                50          7.3    38    11.3
      Prednisone               94                   4.1                75          5.4    79    10.0
       Simazine                99                    3                 73          2.0    66    2.6
     Carbamezapine             101                  2.1                117         1.3    98    25.5
      Fluoxetine               89                   5.5                97          2.3    99    5.5
     Dexamethasone             91                   2.7                86          2.2    88    3.4
         TCEP                  108                  3.1                71          4.3    119   8.1
       Atrazine                100                  2.7                94          1.9    99    2.5
         DEET                  101                  2.7                96          1.6    98    5.5
     Testosterone              82                   3.3                42          2.4    42    21.6
     Norethistrone             79                   2.4                39          1.9    54    2.1
         TCPP                  97                   2.4                119         2.9    74    7.1
      Norgestrel               82                   3.2                57          1.3    55    6.7
     Benzophenone              71                  15.8                95          6.4    93    26.4
   **ESI negative**                                                                            
         PFBA                  95                   4.6                NA           NA    NA     NA
       Naproxen                95                   3.5                89          1.4    80    6.0
         PFBS                  78                   7.1                111         8.0    87    3.6
      Diclofenac               103                  5.4                96          6.0    64    22.0
       Ibuprofen               96                   9.2                92          5.7    96    10.8
         PFOA                  101                  2.3                121         6.4    115   7.4
      Bisphenol A              91                  15.5                97          11.6   87    10.8
      Gemfibrozil              104                  3.7                93          2.7    111   10.0
         PFDA                  97                   3.6                73          15.3   65    13.4
         PFOS                  107                  2.9                94          9.0    89    9.8
     Triclocarban              105                  2.8                97          1.5    107   5.0
       Triclosan               74                   1.1                112         2.8    141   6.7
        PFHxDA                 46                  72.4                56          10.4   66    18.4

*NA* Not Analyzed.

Matrix suppression
------------------

The degree of matrix suppression encountered was analyzed by comparing the instrument response (area count) of the 19 isotopically-labeled standards in the matrix spikes and samples with six instrument blanks spiked at the same concentration. The isotope recovery data in each matrix is presented in Table  [5](#T5){ref-type="table"}. Fluoxetine d~5~, PFBA ^13^C~4~ and diclofenac ^13^C~6~ were the only isotopically-labeled compounds to have \<60% recovery in ultrapure water. The degree of suppression for most compounds increased in the wastewater matrix (250 mL) compared to the surface water (1000 mL) and ultrapure water (1000 mL) spikes even though less volume of the sample was extracted. The RSD for all analytes was below 15% and in most cases below 5%.

###### 

Percent recovery of isotopically labeled standards in different water matrixes (n = 6)

         **Compound**          **Ultrapure water (1000 ml)**   **Surface water (1000 ml)**   **WWTP effluent (250 ml)**               
  --------------------------- ------------------------------- ----------------------------- ---------------------------- ------ ----- ------
      Carbamezapine d~10~                   77                             4.4                           79               2.6    70    4.9
       Caffeine ^13^C~3~                    79                             4.7                           76               3.2    56    4.5
       Trimethoprim d~3~                    67                             4.2                           66               3.1    41    6.4
        Sucralose d~6~                      65                             5.9                           31               3.3    16    4.0
        Primidone d~5~                      81                             3.1                           71               4.0    74    4.3
   Sulfamethoxazole ^13^C~6~                80                             3.6                           30               4.6    28    6.6
         Atrazine d~5~                      70                             3.1                           59               4.1    64    3.9
        Fluoxetine d~5~                     40                             8.3                           35               6.8    40    10.7
           DEET d~6~                        60                             9.2                           70               6.8    75    10.8
         PFBA ^13^C~4~                      15                             2.1                           13               3.4    10    5.2
     Naproxen ^13^C~1~d~3~                  87                             4.5                           94               3.6    75    6.2
      Diclofenac ^13^C~6~                   48                             1.5                           30               7.5    31    14.5
        Ibuprofen d~3~                      86                             6.5                          103               4.7    90    6.5
         PFOA ^13^C~4~                      90                             3.1                          115               14.3   104   0.3
     Bisphenol A ^13^C~12~                  92                             6.9                           70               7.8    83    11.0
       Gemfibrozil d~6~                     86                             3.1                           94               4.6    117   4.9
         PFOS ^13^C~4~                      83                             4.2                           78               7.7    81    5.7
     Triclocarban ^13^C~6~                  61                             7.5                           63               3.3    54    5.7
        Triclosan d~3~                      122                            4.5                           81               3.9    68    5.1

Blank analysis
--------------

As extremely low levels of analytes are quantified in this method, there was a possibility of contamination through various sources. Potential contamination may arise from presence of trace levels of native compound in the isotopically-labeled standards, presence of contamination in the instrument, and low-level contamination from various external sources. Initially pure methanol was injected in both ESI modes to detect the presence of any background contamination due to the solvent or instrument (Additional file [3](#S3){ref-type="supplementary-material"}: Figure S1 and Additional file [4](#S4){ref-type="supplementary-material"}: Figure S2). The target analytes were not found to be present with the exception of DEET. Next methanol blanks were fortified with the isotopically-labeled standards to determine if native compounds were introduced by the isotopes. No indication of target analyes was found in these blanks with the exception of DEET. The area counts of the DEET chromatograms present in the first two types of blanks was very similar indicating that the DEET detected was in the background and not introduced by the isotopically-labeled standard (Additional file [5](#S5){ref-type="supplementary-material"}: Figure S3). The concentration of DEET in the blanks was estimated using the MRL study calibration curve and subsequently the MRL for DEET was increased five times to prevent reporting of false positives. Finally, a number (n = 6) of ultrapure water samples fortified with labeled isotopes were extracted by SPE and analyzed to ensure the absence of unlabeled compounds through the extraction procedure. Further, routine fortified ultrapure water blanks were analyzed along with the samples to check for any contamination. All blanks tested during the course of the study were below MRLs.

Occurrence in water
-------------------

To demonstrate the applicability of this method, samples from three WWTPs, a drinking water treatment plant (DWTP), one ground water and two surface waters (Colorado River and Sacramento River) from around the United States were analyzed. Samples from the three wastewater treatment plants were also analyzed at different treatment points to study treatment efficacy. A summary of the treatment trains for each plant is shown in Additional file [6](#S6){ref-type="supplementary-material"}: Table S3. WWTP 1 served a largely urban population (approximately 500,000 people) with both domestic and industrial contribution. WWTP 2 served a considerably smaller population (approximately 17,000) with 73% of the population aged 65 or older (median age of 72 years). WWTP 3 has a capacity of approximately 70 million gallons per day (MGD) and has a predominantly domestic source of wastewater contribution. Thus, the three plants offered significantly different qualities of wastewater to be tested. DWTP 4 is an indirect potable reuse plant that receives treated wastewater effluent as its source water. The occurrence data for all 36 TOrCs at different treatment points in the four plants is shown in Table  [6](#T6){ref-type="table"} along with the sample volume extracted.

###### 

Occurrence of TOrCs in different water matrices

  **Compound**                      **WWTP 1a**   **WWTP 1b**   **WWTP 2**   **WWTP 3**   **DWTP 4**                                                                                                                                                            
  -------------------------------- ------------- ------------- ------------ ------------ ------------ --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ---------- ---------- ---------- ---------- ----------
  **Volume Extracted (ml)**           **250**       **500**      **500**      **500**      **500**     **500**   **250**   **250**   **500**   **500**   **250**   **250**   **250**   **500**   **250**   **500**   **1000**   **1000**   **1000**   **1000**   **1000**
  ***Pharmaceuticals***                                                                                                                                                                                                                                              
  Carbamezapine                         260           230          230          270          270         260       580       470       460       400      1620      1760       580       590       180       190      \<0.5      \<0.5      \<0.5        1        \<0.5
  Diclofenac                            96           \<15          \<15          78           34        \<15       830       530       420       14        340       370       280       260       120       70        \<8        \<8        \<8        \<8        \<8
  Diltiazem                             NA            NA            NA           NA           NA         NA        NA        NA        NA        NA        280       280       130       59        240       140        75         73        \<2        \<2        \<2
  Diphenhydramine                      1620          1480          1090         280          320         310       25        15        27        \<7      \<73      \<19       \<9       \<5       470       420       \<1        \<1        \<1        \<1        \<1
  Fluoxetine                            160           32            57           41           44         24        79        38        23        34        88        110       89        84        \<9       \<7       \<1        \<1        \<1        \<1        \<1
  Gemfibrozil                          2750          2380          2190          36           38         37      \>6000      400       230       190      5550      5300       75        120       680       540       \<1        \<1        \<1        \<1        \<1
  Ibuprofen                           \>6000         1810          1590          41           41         52      \>6000      50       \<50      \<30      3780      3410      \<15      \<15       180       120       \<15       \<15       \<15       \<15       \<15
  Meprobamate                          1600           650          480          680          670         610       597       421       570       190       690       540       340       280       375       360       \<3        \<3        \<3         3         \<3
  Naproxen                            \>6000          550          300           11           10          4      \>6000      114       28         6       4740      4170       24        30        970       460       \<3        \<3        \<3        \<3        \<3
  Primidone                             200           180          190          170          170         160      1120       620       580       580       370       370       300       300      \<20       \<8       \<4        \<4        \<4        \<4        \<3
  Sulfamethoxazole                     2290           840          1130         1630         1510        990      6080      3910      3010       39       4040      3280      1640       860       590       590        1          1          1          5         \<1
  Trimethoprim                         1110           930          850          130          130         130      1370       30        12        \<2      1510      1420       280       200       830       810      \<0.5      \<0.5      \<0.5        1        \<0.5
  ***Personal-care Products***                                                                                                                                                                                                                                  
  Benzophenone                         6300          2320          1710         650          380         300      4540       310       310       220      1670      1640       340       250       880       280       150        130        114         15         21
  Bisphenol A                           640           140          320          \<90         \<80       \<40       350       20        57        36        240       240       30       \<25       69       \<20       \<20       \<20       \<20       \<20       \<20
  Caffeine                             12000          340          490           6            5          15       6000       22        10        \<8      13680     11320      12        12        11        10        \<3        \<3         4          14        \<3
  DEET                                 3570           540          630           46           45         44       2250       190       170       160       700       350       110       130       93        220       \<3        \<3         5          5          3
  Sucralose                            32000         23000        15000        15600        14400       13500     9000      8170      7570      7950      23000     21000     19000     19000     25000     23000       38         34         47        620        \<31
  TCEP                                  780           690          650          380          350         330       550       330       320       260       630       460       400       370                           \<3        \<3        \<3        \<3        \<3
  TCPP                                 1650          2900          3040         2970         2760       2380      5670      3870      3410      2910      2000      2040      2080      2050       730      1060       \<3        \<3         11         9          3
  Triclocarban                          330           31            42           62           96         38        740       200       68        110       580       520       120        9        50        87        \<2        \<2        \<2        \<2        \<2
  Triclosan                            2250           440          162           85           71         28       4640       103       69        15       1790      2000       52        29       \<39      \<13       \<6        \<6        \<6        \<6        \<6
  ***Perfluorinated compounds***                                                                                                                                                                                                                                
  PFBA                                  \<7           \<3          \<3          \<3          \<3         \<3      \<32      \<19       \<4       \<3       NA        NA        NA        NA        10         9         7         \<3        \<3        \<3        \<3
  PFBS                                  17            10            9            13           14         10        24         9         8         5        \<5       \<4       \<3       \<3       \<3       \<2       \<1        \<1        \<1        \<1        \<1
  PFOA                                   9             7            9            11           45         24         0        46        49        60       \<40      \<31      \<21      \<10       \<4       \<2       \<1        \<1        \<1        \<1        \<1
  PFOS                                 1080           200          190           5            3           2        460        3         2         4        16         9        10         9        530       290       200        \<1        \<1        \<1        \<1
  PFDA                                 \<13           \<8          \<7          \<7          \<7         \<6      \<11      \<10      \<10       \<5      \<12      \<10      \<10      \<10      \<12       \<6       \<3        \<3        \<3        \<3        \<3
  PFHxDA                                \<3           \<2          \<2          \<2          \<2         \<2       \<6       \<4       \<4       \<1      \<11      \<10       \<9       \<9       \<3       \<2       \<1        \<1        \<1        \<1        \<1
  Glucocorticoid                                                                                                                                                                                                                                                     
  Dexamethasone                         19           \<14          \<10         \<22         \<14       \<10       94       \<77      \<26      \<18      \<61      \<11       \<7       \<6      \<44      \<20       \<1        \<1        \<1        \<1        \<1
  Hydrocortisone                       \<20          \<12          \<11         \<48         \<11       \<11       NA       \<150     \<64      \<46      \<17      \<15       \<7       \<5      \<90      \<50       \<4        \<4        \<4         7         \<5
  Prednisone                           \<165         \<61           20          \<61         \<59       \<28       59        NA        NA        NA        NA       \<30      \<25      \<25      \<700     \<200      \<25       \<25       \<25       \<25       \<25
  Triamcinolone                        \<55          \<23          \<21         \<27         \<21       \<21       24       \<14      \<12       \<7      \<61      \<54      \<26      \<12      \<200     \<80       \<7        \<7        \<7        \<7        \<6
  ***Pesticides***                                                                                                                                                                                                                                                   
  Atrazine                             \<10           \<9          \<2          \<2          \<2         \<2      \<20       \<3       \<2       \<2       \<3       \<2       \<2       \<1      \<19       \<6       \<1        \<1        \<1        \<1        \<1
  Simazine                             \<21           \<3          \<2          \<3          \<3         \<2      \<40       \<6        4         3        \<6       \<4       \<2       \<2      \<38      \<12       \<2        \<2        \<2         2         \<2
  Androgen                                                                                                                                                                                                                                                           
  Testosterone                          14            \<2          \<2           15           14         \<2       15         4         3        \<2      \<11       \<8       \<5       \<2        9         9        \<1        \<1        \<1        \<2        \<1
  ***Progestin***                                                                                                                                                                                                                                                    
  Norethistrone                        \<19          \<16          \<5          \<5          \<4         \<2       100        6        \<5       \<5      \<30       \<7       \<3       \<2      \<18       \<7       \<3        \<3        \<3        \<3        \<3
  Norgestrel                            93            10            8            18           5           4        19         6         7         3        620       230       \<3       \<2       110       110       \<4        \<4        \<3        \<3        \<3

Attached excel file to be placed in main text.

*NA* Not analyzed.

Sucralose (9000--32000 ng/L) and caffeine (6000--13280 ng/L) were present at the highest concentration in the influent of all WWTPs. All pharmaceuticals analyzed in the influent of the three WWTPs were detected with the exception of diphenhydramine in WWTP 3. Concentrations of diabetes and heart-related pharmaceuticals like gemfibrozil, diclofenac, and primidone were significantly higher in the raw sewage of WWTP 2 (the plant serving the dominantly elderly community) compared to the other two WWTPs. Conversely, industrial compounds like benzophenone, PFOS, DEET, and bisphenol A were found at higher concentrations in WWTP 1, potentially confirming the significant industrial input.

The mean effluent concentrations in all WWTPs of artificial sweetener sucralose (13,860) and flame-retardant TCPP (2595 ng/L) were extremely high compared to the other analyzed TOrCs. Their concentrations remained fairly constant throughout the plant indicating that they may be robust and suitable markers for wastewater influence in drinking water sources. Six pharmaceuticals (carbamazepine, gemfibrozil, meprobamate, naproxen, primidone and sulfamethoxazole) were detected in the effluent of all WWTPs with mean concentrations between 85--755 ng/L. Average concentration of sulfamethoxazole (755 ng/L) and gemfibrozil (634 ng/L) were highest in the WWTP effluent for pharmaceuticals. The GR compounds were present at significantly lower concentrations in the influent and not detected in the final effluent in all three WWTPs. However, these compounds still need to be monitored closely as even trace amounts have been shown to have adverse effects to wildlife \[[@B8],[@B45]\]. PFOS was the dominant PFC in terms of detection and concentration while the longer chain PFCs (PFDA and PFHxDA) were not detected at any point in all three WWTPs. PFBS was detected in the effluent of two WWTPs (1 and 2) but at concentration \<10 ng/L while PFBA was not detected in any of the effluent samples. Norgestrel was the more frequently detected progestin, present in two effluent WWTP samples (WWTP 1 and 2), while norethisterone was never detected in the effluent. The pesticide atrazine was not detected in any of the samples analyzed throughout the study.

To study the treatment efficacy of the WWTPs, samples were collected at different points in the plant. Further, WWTP 1 had water split into two parallel trains after primary treatment: conventional (activated sludge followed by chlorination) and advanced (advanced air activated sludge, granular media filtration and UV disinfection). The biggest factor in removal of TOrCs between the two treatment trains in WWTP 1 was the type of activated sludge (AS) used. The advanced air activated sludge (AAS) process provided significantly lower concentration of most TOrCs as compared to the AS effluent in the conventional train. The sand filter in WWTP 2 did not have much attenuation of TOrCs, similar to previous literature \[[@B46]\]. Compounds like diclofenac, sulfamethoxazole, naproxen, and triclosan were well removed by the free chlorine disinfection step which is consistent with previously published literature \[[@B6]\]. Conversely, compounds such as DEET, TCPP, TCEP and caffeine are known to be recalcitrant at chlorine doses supplied in conventional treatment plants and hence were not well removed in the chlorination step in both treatment plants. The UV disinfection process (in WWTP 1b) was not very effective in attenuation of TOrCs without the addition of hydrogen peroxide. In DWTP 4, very few TOrCs were attenuated by micro-filtration process, which is consistant with previous literature \[[@B47]\]. However, almost no traces of any TOrCs were detected after the reverse osmosis (RO) process. Only six (benzophenone, diltiazem, PFBA, PFOS, sucralose and sulfamethoxazole) of the 36 measured TOrCs were present after RO treatment in DWTP 4. Of these six, only benzophenone and PFOS were present at concentrations \>100 ng/L.

Two surface waters from the Colorado River (sampled at Avra Valley, AZ through the CAP canal) and Sacramento River were analyzed using this method. Eleven target compounds were detected in the Colorado River water while seven were seen in the Sacramento River sample. Six of the target analytes (sucralose, meprobamate, caffeine, DEET, TCPP and benzophenone) were common to both waters. Sucralose was present at the highest concentration in the Colorado River samples at 620 ng/L while in the Sacramento River sample it was measured at 47 ng/L. Commercially used compounds like benzophenone and TCPP were detected at higher concentrations in the Sacramento river while all the other analytes detected were higher in the Colorado River sample. The groundwater sample collected from Tucson had trace amounts of DEET and TCPP (\<5 ng/L), and benzophenone at 21 ng/L but all other TOrCs were not detected. Although the sampling events were limited, the data generally correlate with previous studies and hence prove the viability of the analytical method.

Conclusion
==========

The analytical method presented above allows for rapid, high-throughput detection and quantitation of up to 36 TOrCs including pharmaceuticals, personal care products and steroid hormones using UHPLC-MS/MS. The use of a single all-inclusive SPE method coupled to UHPLC MS/MS provides significant time and labor savings while achieving reporting limits of low ng/L for all analytes. The method has been applied to a wide-range of aqueous matrices. The authors suggest using routine blank analysis, matrix spike recoveries and isotopically-labeled standards for obtaining most accurate results when analyzing different water matrixes.
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Overlaid EIC traces of the most abundant transition in ESI positive of a methanol blank. The peak at 5.6 min is DEET.
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Overlaid EIC traces of the most abundant transition in ESI negative of a methanol blank.

###### 

Click here for file

###### Additional file 5: Figure S3

Overlaid EIC of the most abundant transition of DEET in a methanol blank and fortified methanol blank.
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